Nicotine's surprising effect on gut microbiota and metabolism uncovered

NewsGuard 100/100 Score

A recent Scientific Reports study investigates the impact of nicotine exposure on host nutritional status, gut microbial metabolites, and metabolic homeostasis.

Study: Gut microbial metabolites reveal diet-dependent metabolic changes induced by nicotine administration. Image Credit: Danijela Maksimovic/Shutterstock.comStudy: Gut microbial metabolites reveal diet-dependent metabolic changes induced by nicotine administration. Image Credit: Danijela Maksimovic/Shutterstock.com

Background

The gut microbiome is associated with many physiological functions that include metabolic homeostasis. Several studies have revealed that gut microbiome dysbiosis leads to the development of many metabolic disorders, such as type 2 diabetes mellitus.

Gut microbiota synthesizes a broad spectrum of bioactive metabolites that signal messengers and indicators of microbial function.

The composition and function of these microbes are modulated via diet and daily environmental factors. Host metabolism is significantly affected by diet-derived metabolites synthesized by gut bacteria.

Fermentation of indigestible polysaccharides by gut microbe leads to the generation of short-chain fatty acids (SCFA), which improves weight gain resistance and insulin sensitivity.

The gut microbiota is associated with synthesizing diverse fatty acid variants, such as hydroxy-, conjugated-, and oxy-fatty acids, which promotes host resistance to high-fat diet (HFD)-induced obesity.

The synthesis of fatty acid metabolites by gut microbiota, depending on the dietary environment of the host, plays a crucial role in improving host metabolic functions.

Cigarette smoking is a key preventable factor that enhances mortality. The majority of smokers are susceptible to developing cardiovascular issues, chronic obstructive pulmonary disease (COPD), and various types of cancers.

Several studies have also indicated that exposure to second-hand smoke contributes to the development of pathogen-related infections and aggravates asthma, inflammatory bowel disease, and Crohn’s disease.

Nicotine is the primary active ingredient in tobacco. Besides being absorbed by the pulmonary alveoli, they are also found in the skin and gastrointestinal tract. Many beneficial and detrimental effects of nicotine have been identified.

As per the benefits, nicotine regulates energy intake by modulating appetite. As regards the detrimental effects, previous studies have documented evidence that indicated how nicotine exposure leads to the development of hepatic steatosis and cardiovascular diseases. 

Nicotine exposure can alter host metabolism by inducing changes in the gut microbiota and its metabolites.

It is imperative to understand the underlying mechanism that controls the interplay between gut environment, diet-derived microbial metabolites, and host metabolic homeostasis against nicotine exposure.

About the study

The current study evaluated how nicotine exposure affected the metabolic regulatory mechanisms by inducing changes in gut microbial composition and their metabolic products.

A mouse model was used to understand the underlying mechanism responsible for the observed effect. A global meta-analysis was conducted to understand how nicotine exposure alters gut microbiota, affecting host metabolism.

For experimental purposes, seven-week-old male mice with comparable body weights were divided into two groups: the normal diet (ND) group and the high-fat diet (HFD) group.

These mice were exposed to nicotine or saline for four weeks. After seven to eleven weeks of intervention, SCFAs and long-chain fatty acid metabolite levels were estimated.

The body weight of the study mice was also measured once a week. Blood samples were collected for analysis.

Study findings

The current study reflects the intense interplay of the gut microbiota and their metabolites and host metabolic characteristics in the backdrop of nicotine exposure.

Intraperitoneal nicotine administration was found to have a profound effect on weight regulation and metabolic phenotypes. This effect was independent of reduced caloric intake.

Mechanistically, the nicotine-induced body weight suppression was modulated by specific gut bacteria, including Lactobacillus spp, synthesizing KetoB (linoleic acid) during HFD intake alone.

Several studies have shown that nicotine decreases body weight and food intake via the hypothalamic melanocortin system.

A decrease in the relative abundance of Lactobacillus spp. occurred in response to high HFD exposure. This bacterial population spiked in the presence of nicotine, particularly under HFD conditions.

The pair-feeding model in this study indicated that the main mechanism of weight control induced by nicotine administration was linked to decreased caloric intake. No specific correlation was observed between caloric intake and body weight even under ad libitum conditions. 

Although nicotine administration resulted in a reduction in caloric intake in both ND and HFD groups, a greater reduction in body weight specifically occurred in the HFD group.

This result indicates that diet-dependent factors contribute to weight loss triggered by nicotine treatment. An elevated concentration of LCFAs that impacted gut microbial sensitivity to nicotine was found in the HFD group.

The increase in plasma non-esterified fatty acid (NEFA) after intraperitoneal nicotine administration in HFD-fed mice indicates the role of nicotine in promoting lipolysis.

The gut microbiota depletion model using antibiotic treatment in HFD-fed mice revealed that gut microbiota and their dietary fatty acid-derived metabolites are crucial in nicotine-induced body weight loss. The treated mice also significantly reduced caloric intake following nicotine administration.

Conclusions

The current study identified Keto B as a regulator of body weight loss associated with nicotine administration.

It highlighted the broad interplay of gut microbe in response to smoking that influences varied metabolic conditions including lowering of body weight.

Notably, the use of microbes in weight reduction has been reflected in this study.

Journal reference:
Dr. Priyom Bose

Written by

Dr. Priyom Bose

Priyom holds a Ph.D. in Plant Biology and Biotechnology from the University of Madras, India. She is an active researcher and an experienced science writer. Priyom has also co-authored several original research articles that have been published in reputed peer-reviewed journals. She is also an avid reader and an amateur photographer.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Bose, Priyom. (2024, January 15). Nicotine's surprising effect on gut microbiota and metabolism uncovered. News-Medical. Retrieved on April 19, 2024 from https://www.news-medical.net/news/20240115/Nicotines-surprising-effect-on-gut-microbiota-and-metabolism-uncovered.aspx.

  • MLA

    Bose, Priyom. "Nicotine's surprising effect on gut microbiota and metabolism uncovered". News-Medical. 19 April 2024. <https://www.news-medical.net/news/20240115/Nicotines-surprising-effect-on-gut-microbiota-and-metabolism-uncovered.aspx>.

  • Chicago

    Bose, Priyom. "Nicotine's surprising effect on gut microbiota and metabolism uncovered". News-Medical. https://www.news-medical.net/news/20240115/Nicotines-surprising-effect-on-gut-microbiota-and-metabolism-uncovered.aspx. (accessed April 19, 2024).

  • Harvard

    Bose, Priyom. 2024. Nicotine's surprising effect on gut microbiota and metabolism uncovered. News-Medical, viewed 19 April 2024, https://www.news-medical.net/news/20240115/Nicotines-surprising-effect-on-gut-microbiota-and-metabolism-uncovered.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Is there a neurobiological association between childhood trauma, alexithymia, and long-term nicotine smoking?